Tags: adjuvants, biochemistry, bioengineering, immune response, immunology, vaccine design, yeastalectiniblung canceradjuvantchemotherapy
| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | Judy George MedPage Today Medical reporter, writer. | ||
| 2 | <em>The Scientist</em> Staff The Scientist Exploring Life, Inspiring Innovation. | New Frontiers in Vaccine Development - about 2 months ago | |
| 3 | Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA | ||
| 4 | Meagan Parrish Pharma Voice Senior editor @industrydive.
Pharma world follower. Wisconsin, USA | Pharma takes aim at a wily foe — the Epstein-Barr virus - 3 months ago Pharma’s ‘it’ therapy — a new drug class gaining steam - 5 months ago Red Jacket: Helen Sabzevari, an immunotherapy pioneer - over 1 year ago | |
| 5 | Hannah Thomasy, PhD The Scientist Freelance science writer. PhD. Seattle & Toronto | A Neural Thermostat Sets the Intensity of Immune Responses - 3 months ago To Boldly Go Where No Squid Has Gone Before - about 1 year ago | |
| 6 | Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia | A potential MS ‘game changer’ could bring more safety to the table — even against viruses - 6 months ago 4 offbeat biotechs making a splash in the life sciences - 9 months ago | |
| 7 | Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts | A biotech’s binary bet ends badly - 8 months ago | |
| 8 | Brittany Trang STAT News Health care business reporter. PhD. Indie rock fan. | ||
| 9 | Carissa Wong Nature Freelance reporter Nature. She/Her. | ||
| 10 | Meghana Keshavan STAT News Biotech nerd and writer @statnews. | How resurrecting extinct species might impact medicine - 10 months ago |